Anti-PD-1 monoclonal antibody
Proposed is an anti-PD-1 monoclonal antibody or an antigen binding fragment thereof, comprising a heavy chain variable region having at least one of the amino acid sequences listed below: (1) the amino acid sequence shown in SEQ ID NO: 1; (2) the amino acid sequence shown in SEQ ID NO: 3; (3) the amino acid sequence shown in SEQ ID NO: 5; and (4) an amino acid sequence having more than one conservative amino acid mutation compared with (1)-(3).
1. An antibody or antigen-binding fragment thereof, comprising:
a heavy chain CDR1 comprising the amino acid sequence of GFTFSSYG (SEQ ID NO:14), CDR2 comprising the amino acid sequence of ISGGGRDT (SEQ ID NO:15), and CDR3 comprising the amino acid sequence of ARQKGEAWFAY (SEQ ID NO:16); and
a light chain CDR1 comprising the amino acid sequence of ESVDNYGISF (SEQ ID NO:17), CDR2 comprising the amino acid sequence of AAS (SEQ ID NO:18), and CDR3 comprising the amino acid sequence of QQSKEVPWT (SEQ ID NO:19).
2. The antibody or antigen-binding fragment thereof according to claim 1 , comprising a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 1, 3, or 5.
3. The antibody or antigen-binding fragment thereof according to claim 1 , comprising a light chain variable region comprising the amino acid sequence of SEQ ID NO: 2, 4, or 6.
4. The antibody or antigen-binding fragment thereof according to claim 1 , comprising:
a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 1 and a light chain variable region comprising the amino acid sequence of SEQ ID NO: 2;
a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 3 and a light chain variable region comprising the amino acid sequence of SEQ ID NO: 4; or
a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 5 and a light chain variable region comprising the amino acid sequence of SEQ ID NO: 6.
5. The antibody or antigen-binding fragment thereof according to claim 1 , wherein the antibody or antigen-binding fragment thereof is humanized.
6. The antibody or antigen-binding fragment thereof according to claim 1 , comprising:
a heavy chain variable region comprising the amino acid sequence of SEQ ID NO:3, and
a light chain variable region comprising the amino acid sequence of SEQ ID NO:4.